SiHa IFITM1+IFITM3 KO

SiHa cell line with CRISPR Cas9 abolished expression of Interferon Induced Transmembrane Protein 1 (IFITM1) and 3 (IFITM3)

Contributors

Inventor Institute
Marta Nekulová Masaryk Memorial Cancer Institute
Cat. #: 162300
Organism: Human
Tissue: Uterus
Gender: Female
Model: Transgenic (KO)
Morphology: Epithelial
Growth properties: Adherent
Product description: SiHa cell line with CRISPR Cas9 abolished expression of Interferon Induced Transmembrane Protein 1 (IFITM1) and 3 (IFITM3)
Gender: Female
CRISPR: Yes
Parental cell line: SiHa
Model description: CRISPR Cas9 abolished expression of Interferon Induced Transmembrane Protein 1 (IFITM1) and Interferon Induced Transmembrane Protein 3 (IFITM3)
disease: Cancer
Format: Frozen
Storage conditions: Liquid Nitrogen
Growth medium: RPMI 1640 medium supplemented with 10% (v/v) fetal bovine serum and 1% penicillin/streptomycin
Atmosphere: 5% CO2

Related Tools for Cell lines

Cat. # Tool Name
151450 JIM3 Cell Line Key Info View Tool
151463 Omega-E Packaging Cell Line Key Info View Tool
151503 1-7 CE1 Cell Line Key Info View Tool
151558 MEF Trex1 KO Cell Line Key Info View Tool
151665 MEF PKCe KO Cell Line Key Info View Tool

Related News

UM-UC-10 Cell Line. Image courtesy of the European Collection of Authenticated Cell Cultures (ECACC), UK.
Cell Lines

Popular cell lines now available only from CancerTools.org

Read More
Cell Lines

New cell lines: murine melanocyte and melanoblast cell lines from Dr. Elena Sviderskaya

Read More
Image Reference: 2x PTEN -/- mouse prostate cancer cell lines (MuCap system). Histology staining of syngraft tumours (Van Duijn et al., 2018).
Cell Lines

38 new prostate cancer cell lines

Read More

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.